Delhi: Delay Announced in Sputnik V Vaccine Rollout to NCR Hospitals
By: Mahak Arora
The rollout of Sputnik-V, the first foreign state-sponsored vaccine to get emergency use approval from India's Drugs Controller General, around hospitals in Delhi has been delayed by five days, officials told the media on Sunday.
“It has been pushed back for now as there is a delay from the manufacturer’s side. We are expecting that we will receive it sometime next week but they have not confirmed the date yet,” Dinesh Vashist, VP Operations at Madhukar Hospital, told The Indian Express.
Both Madhukar Rainbow Children’s Hospital and Indraprastha Apollo Hospital had stated that they will be making the vaccine available to the people of Delhi from June 20 onwards. However, the roll-out did not begin on Sunday and hospitals were told that the Russian vaccine will be available in NCR from Friday onwards.
Russia's Gamaleya National Research Institute of Epidemiology and Microbiology has developed Sputnik-V and the Russian Direct Investment Fund (RDIF) is marketing it globally. It is the third COVID-19 vaccine to get emergency use authorization from the Centre. The other two are the Oxford-AstraZeneca joint venture Covishield (licensed to be produced in India by the Pune based Serum Institute) and Bharat Biotech’s Covaxin.
In India, the Hyderabad-based pharma giant Dr Reddy’s Laboratories, the local marketing partner for the vaccine, has been importing the shots from Russia.
According to the Union health ministry, all three vaccines would be available for free at government immunization centres from June 22 onwards. In the case of private players, however, the Centre has fixed the MRP for a single dose of the Sputnik-V vaccine at ₹1,145. Meanwhile, Covishield is available at ₹780 per dose and Covaxin at ₹1,410 for a single dose.
As per data published on Friday, a total of 77,345 doses of COVID vaccine were administered in Delhi, out of which 62,230 people were given the first dose and 15,115 were given the second dose.
Join India’s only non-profit Student Journalism platform and put your students ahead in the race. For more information, write to us at email@example.com.